Di Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Di Wang has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Changfu Li
Department of Urology Harbin Medical University Cancer Hospital Harbin 150001 China
2 shared publicationsDayong Hou
NHC Key Laboratory of Molecular Probes and Targeted Theranostics The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin Medical University Harbin 150001 China
2 shared publicationsFeng Wen
BGI Research Beijing 102601 China
2 shared publicationsFengpu Fan
BGI Research Beijing 102601 China
2 shared publicationsGuixiang Xie
BGI Research Chongqing 401329 China
2 shared publicationsHang Su
BGI Research Beijing 102601 China
2 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
HAAO‑derived quinolinic acid fuels FDPS‑dependent AR signaling and sensitizes prostate cancer to combination therapy
Emerging evidence highlights that metabolic reprogramming profoundly shapes the tumor microenvironment and immune evasion in prostate cancer. However, the functional role and mechanisms of tryptophan metabolism in prostate cancer progression remain unclear. Through single-cell transcriptomic analysis, we identified one tumor cell subtype characterized by high expression of 3-hydroxyanthranilate 3,4-dioxygenase (HAAO) and enhanced kynurenine pathway activity. This subpopulation leads to the accumulation of quinolinic acid (QA), a metabolic intermediate that could activate the mevalonate (MVA) pathway. Mechanistically, QA directly binds to and stabilizes farnesyl diphosphate synthase (FDPS), a key MVA pathway enzyme, thereby enhancing cholesterol biosynthesis and fueling androgen receptor (AR)-driven transcriptional programs. This HAAO/QA-FDPS axis establishes a metabolic crosstalk that links tryptophan catabolism to lipid metabolism, sustaining prostate tumor progression. Furthermore, an integrated prognostic model incorporating this pathway signatures outperforms other clinical variables alone, and HAAO-high tumors exhibit heightened sensitivity to combined inhibition of the kynurenine and AR pathways. Our study unveils a novel metabolic vulnerability in prostate cancer and provides a mechanistic rationale for targeting the HAAO/QA-FDPS axis for therapy.
- 16 June 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
Open AccessHAAO‑derived quinolinic acid fuels FDPS‑dependent AR signaling and sensitizes prostate cancer to combination therapy
Emerging evidence highlights that metabolic reprogramming profoundly shapes the tumor microenvironment and immune evasion in prostate cancer. However, the functional role and mechanisms of tryptophan metabolism in prostate cancer progression remain unclear. Through single-cell transcriptomic analysis, we identified one tumor cell subtype characterized by high expression of 3-hydroxyanthranilate 3,4-dioxygenase (HAAO) and enhanced kynurenine pathway activity. This subpopulation leads to the accumulation of quinolinic acid (QA), a metabolic intermediate that could activate the mevalonate (MVA) pathway. Mechanistically, QA directly binds to and stabilizes farnesyl diphosphate synthase (FDPS), a key MVA pathway enzyme, thereby enhancing cholesterol biosynthesis and fueling androgen receptor (AR)-driven transcriptional programs. This HAAO/QA-FDPS axis establishes a metabolic crosstalk that links tryptophan catabolism to lipid metabolism, sustaining prostate tumor progression. Furthermore, an integrated prognostic model incorporating this pathway signatures outperforms other clinical variables alone, and HAAO-high tumors exhibit heightened sensitivity to combined inhibition of the kynurenine and AR pathways. Our study unveils a novel metabolic vulnerability in prostate cancer and provides a mechanistic rationale for targeting the HAAO/QA-FDPS axis for therapy.
- 7 October 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (12)
Tumors with microsatellite instability upregulate TREX1 to escape antitumor immunity
Currently, it remains largely unclear how MSI-H/dMMR tumors, despite heightened immune pathway activation and antigenic mutation accumulation, evade immune elimination and promote tumorigenesis. Our study showed that dMMR tumors accumulate cytosolic double-stranded DNA, activating the cGAS–IFN pathway and upregulating DNA-digesting enzyme TREX1. In immunocompetent mice, Trex1 depletion in MSI-H/dMMR tumors abolished tumor formation in a CD8+ T cell–dependent manner, suggesting its critical role in enabling these tumors to evade immune attack. Mechanistically, Trex1 loss amplified tumor-intrinsic cGAS–STING signaling, promoted the activation of CD8+ T cells, and triggered systemic antitumor immunity. Critically, ablating cGAS–STING signaling in MSI-H/dMMR tumors abolished the immune boost from TREX1 deletion, revealing the critical role MSI-H/dMMR tumor-intrinsic cGAS–STING pathway. Furthermore, Trex1 inhibition specifically reduced MSI-H/dMMR tumors growth in vivo, highlighting its clinical potential. Together, we identify the cGAS–STING-TREX1 loop as a key immune escape mechanism in MSI-H/dMMR cancers, suggesting TREX1 inhibition could enhance immunotherapy for these patients.
- 7 October 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (12)
Tumors with microsatellite instability upregulate TREX1 to escape antitumor immunity
Currently, it remains largely unclear how MSI-H/dMMR tumors, despite heightened immune pathway activation and antigenic mutation accumulation, evade immune elimination and promote tumorigenesis. Our study showed that dMMR tumors accumulate cytosolic double-stranded DNA, activating the cGAS–IFN pathway and upregulating DNA-digesting enzyme TREX1. In immunocompetent mice, Trex1 depletion in MSI-H/dMMR tumors abolished tumor formation in a CD8+ T cell–dependent manner, suggesting its critical role in enabling these tumors to evade immune attack. Mechanistically, Trex1 loss amplified tumor-intrinsic cGAS–STING signaling, promoted the activation of CD8+ T cells, and triggered systemic antitumor immunity. Critically, ablating cGAS–STING signaling in MSI-H/dMMR tumors abolished the immune boost from TREX1 deletion, revealing the critical role MSI-H/dMMR tumor-intrinsic cGAS–STING pathway. Furthermore, Trex1 inhibition specifically reduced MSI-H/dMMR tumors growth in vivo, highlighting its clinical potential. Together, we identify the cGAS–STING-TREX1 loop as a key immune escape mechanism in MSI-H/dMMR cancers, suggesting TREX1 inhibition could enhance immunotherapy for these patients.
- Open Access
- 5 June 2025
- Published by Wiley in Advanced Science
- Vol. 12 (33) , e00216
Single‐Cell and Spatial Transcriptomic Profiling of Penile Squamous Cell Carcinoma Reveals Dynamics of Tumor Differentiation and Immune Microenvironment
Penile squamous cell carcinoma (PSCC) is a highly aggressive malignancy without effective treatment due to limited knowledge of its development and tumor microenvironment (TME). In this study, single‐nucleus RNA sequencing (snRNA‐seq) and high‐resolution spatial transcriptomics are employed to comprehensively investigate the development trajectories and the TME. The results revealed that PSCC cells mimicked the differentiation and tissue organization of normal penile epithelium, independent of the human papillomavirus (HPV) infection status. Notably, a spatial subtype, Tum_1, appeared at early stage of tumor differentiation and in tumor–normal boundary regions. This subtype exhibited enhanced basal‐like and stemness features and showed high LAMC2 expression, which activated laminin‐integrin signaling via ITGA6/ITGB4, promoting tumor invasiveness. Furthermore, the results indicated that HPV‐positive basal stem‐like neoplasms dampened the immune function of T cells and macrophages, promoting an immunosuppressive environment that facilitates tumor progression. Supporting this, the patients with head and neck squamous cell carcinoma and lung squamous cell carcinoma who have high expression of HPV‐positive Tum_1 signatures derived greater benefit from PD‐1 blockade therapy. In summary, the findings provide a comprehensive spatial landscape of the PSCC TME and suggest potential treatment approaches targeting laminin‐integrin interaction and immunotherapy, especially in HPV‐positive patients.
- 5 June 2025
- Published by Wiley in Advanced Science
- Vol. 12 (33) , e00216
Open AccessSingle‐Cell and Spatial Transcriptomic Profiling of Penile Squamous Cell Carcinoma Reveals Dynamics of Tumor Differentiation and Immune Microenvironment
Penile squamous cell carcinoma (PSCC) is a highly aggressive malignancy without effective treatment due to limited knowledge of its development and tumor microenvironment (TME). In this study, single‐nucleus RNA sequencing (snRNA‐seq) and high‐resolution spatial transcriptomics are employed to comprehensively investigate the development trajectories and the TME. The results revealed that PSCC cells mimicked the differentiation and tissue organization of normal penile epithelium, independent of the human papillomavirus (HPV) infection status. Notably, a spatial subtype, Tum_1, appeared at early stage of tumor differentiation and in tumor–normal boundary regions. This subtype exhibited enhanced basal‐like and stemness features and showed high LAMC2 expression, which activated laminin‐integrin signaling via ITGA6/ITGB4, promoting tumor invasiveness. Furthermore, the results indicated that HPV‐positive basal stem‐like neoplasms dampened the immune function of T cells and macrophages, promoting an immunosuppressive environment that facilitates tumor progression. Supporting this, the patients with head and neck squamous cell carcinoma and lung squamous cell carcinoma who have high expression of HPV‐positive Tum_1 signatures derived greater benefit from PD‐1 blockade therapy. In summary, the findings provide a comprehensive spatial landscape of the PSCC TME and suggest potential treatment approaches targeting laminin‐integrin interaction and immunotherapy, especially in HPV‐positive patients.
- Open Access
- 25 October 2024
- Published by Springer Nature in Research Square
A spatially resolved whole-layers landscape of bladder cancer deciphers dynamic invasive progression
Cancer invasion is driven by complex interactions between tumor cells and tumor microenvironment (TME), which promote cancer cell plasticity and remodel the TME to support invasive behavior. In bladder cancer, invasion into the muscularis propria reduces the five-year survival rate to below 30%. Despite this clinical significance, the molecular mechanisms underlying bladder cancer invasion remain poorly understood. Current studies predominantly focus on the comparison between non-invasive and invasive tumor tissue, leaving dynamic TME variation largely unexplored. Leveraging the capabilities of spatial information, we integrated Stereo-seq spatial transcriptomics with single-nucleus RNA sequencing (snRNA-seq) on whole-layers bladder cancer specimens. These integrated datasets delineated a spatially resolved whole-layers landscape of bladder cancer at single cell resolution, elucidating the localization and function of principle cell types during the invasive process. We discovered a bladder cancer invasive leading structure characterized by EPCAM and KRT17 co-expressing, whose plasticity is induced and maintained through interactions with POSTN+ cancer associated fibroblasts (CAFs) and APOE+ macrophages. Additionally, we uncovered the specific spatial distribution of different CAF subtypes during bladder cancer progression, highlighting their roles in shaping distinct TME. Notably, we revealed a progressive increase in immunosuppressive states from superficial to muscle-invading bladder tumors. Our findings underscore the orchestrated dynamics of bladder cancer progression driven by intricate tumor-stroma interactions within the TME. These insights provide a framework for understanding invasive behavior in other muscle-invasive cancers, guiding future research into shared mechanisms of tumor progression and microenvironmental remodeling.
- 25 October 2024
- Published by Springer Nature in Research Square
Open AccessA spatially resolved whole-layers landscape of bladder cancer deciphers dynamic invasive progression
Cancer invasion is driven by complex interactions between tumor cells and tumor microenvironment (TME), which promote cancer cell plasticity and remodel the TME to support invasive behavior. In bladder cancer, invasion into the muscularis propria reduces the five-year survival rate to below 30%. Despite this clinical significance, the molecular mechanisms underlying bladder cancer invasion remain poorly understood. Current studies predominantly focus on the comparison between non-invasive and invasive tumor tissue, leaving dynamic TME variation largely unexplored. Leveraging the capabilities of spatial information, we integrated Stereo-seq spatial transcriptomics with single-nucleus RNA sequencing (snRNA-seq) on whole-layers bladder cancer specimens. These integrated datasets delineated a spatially resolved whole-layers landscape of bladder cancer at single cell resolution, elucidating the localization and function of principle cell types during the invasive process. We discovered a bladder cancer invasive leading structure characterized by EPCAM and KRT17 co-expressing, whose plasticity is induced and maintained through interactions with POSTN+ cancer associated fibroblasts (CAFs) and APOE+ macrophages. Additionally, we uncovered the specific spatial distribution of different CAF subtypes during bladder cancer progression, highlighting their roles in shaping distinct TME. Notably, we revealed a progressive increase in immunosuppressive states from superficial to muscle-invading bladder tumors. Our findings underscore the orchestrated dynamics of bladder cancer progression driven by intricate tumor-stroma interactions within the TME. These insights provide a framework for understanding invasive behavior in other muscle-invasive cancers, guiding future research into shared mechanisms of tumor progression and microenvironmental remodeling.